The latest news & events
Keep up to date with company updates, industry news, investor
press releases and event information.
Kneat to return to US Validation Week 2018 in San Diego
Join us at IVT US Validation Week 2018, October 22-24 IVT’s 24th Annual Validation Week will offer four tracks —…
Read More
Kneat to exhibit at 2018 PDA-FDA Joint Regulatory Conference
Join us at the 2018 PDA-FDA Joint Regulatory Conference, September 24-26 The PDA/FDA Joint Regulatory Conference is now in its…
Read More
Kneat tier one client to present at BioTalk 2019
Join us at BioTalk 2019, September 19-20, Titanic Chaussee Berlin BioTalk is a leading annual meeting which brings together some…
Read More
Tier One Customer Scaling Kneat’s Platform to New Processes
HALIFAX, August 22, 2018/CNW/ – kneat.com, inc. (TSX-V: KSI) (“Kneat”) is pleased to announce that another of its tier one pharmaceutical customers is expanding their use of Kneat’s software platform. The first contract with this customer was announced in February 2018.
Read More
Kneat Customer Purchases Additional Licenses
HALIFAX, July 23, 2018/CNW/ – kneat.com, inc. (TSX-V: KSI) (“Kneat”) is pleased to announce that one of its customers has further expanded its user base of the Kneat Gx platform by purchasing additional on-premise licenses. This order represents a twenty-eight percent increase in licenses purchased
Read More
Multinational Pharmaceutical Manufacturer selects Kneat
HALIFAX, July 16, 2018/CNW/ – kneat.com, inc. (TSX-V: KSI) (“Kneat”) is pleased to announce that it will be deploying its Software as a Service (“SaaS”) platform for the biotechnology division of a multinational pharmaceutical manufacturer with more than 70 manufacturing sites worldwide.
Read More
Kneat Contracts with Global Healthcare Company
HALIFAX, July 12, 2018/CNW/ – kneat.com, inc. (TSX-V: KSI) (“Kneat”) is pleased to announce its fourth new top tier customer win of 2018. One of the world’s leading research-based developers of pharmaceuticals has chosen Kneat’s technology to digitize its commissioning, qualification and validation
Read More
Leading Global Biotech Selects Kneat
HALIFAX, June 14, 2018 /CNW/ – kneat.com , inc. (TSXV: KSI) (“Kneat”) is pleased to announce a new customer win. This customer, a global leader in biotechnology, is deploying Kneat’s software to a number of their sites after successfully completing product trials at an initial test site.
Read More
kneat.com, inc. Announces Closing Of $6.185 Million Brokered Private Placement
HALIFAX, April 10, 2018 – kneat.com , inc. (TSX-V: KSI) (“ Kneat ” or the “ Company ”) is pleased to announce that it has closed its previously announced brokered private placement for aggregate gross proceeds of $ $6,184,647 (the “Offering”), which was increased from the previously announced
Read More
Kneat Announces Expansion of Sales Team in The United States
HALIFAX, March 27, 2018 – kneat.com, inc. (TSX-V: KSI) (“Kneat” or the “Company”) announces the appointment of Mr. Camilo Ruan as Director of Sales for the western region of the United States. Mr. Ruan has considerable experience selling enterprise software and will focus his efforts on a region
Read More
Kneat.com Announces $5 Million Brokered Private Placement
HALIFAX, March 12, 2018 – kneat.com , inc. (TSX-V: KSI) (“ Kneat ” or the “ Company ”) is pleased to announce that it intends to complete a brokered private placement for aggregate gross proceeds of up to $5.0 million (the “Offering”). The Company intends to issue 5,555,556 common shares at an
Read More
Leading Contract Laboratory Services Company selects Kneat for its Validation Life Cycle Management
HALIFAX, February 26, 2018/CNW/ – kneat.com , inc. (TSX-V: KSI) (“ kneat.com ”, “ Kneat ”, or the “ Company ”) is pleased to announce that a leader in laboratory services to the life sciences industry has selected the Kneat platform to streamline and automate its equipment and instrumentation
Read MoreContact
Talk to us
Find out how Kneat can make your validation easier, faster, and smarter.
Start your paperless validation revolution by speaking to our experts.